How can I join the NINLARO®(ixazomib) community?

Extend your support network by signing up today!

You don't have to face this diagnosis alone. There are others out there just like you, and together you can share knowledge and support. Join the multiple myeloma and NINLARO support community. Sign up and receive the following:

Find Patient Support events near you

A great way to learn, meet others, and find support

Sign up for online and in-person events where you can listen to leading medical experts discuss multiple myeloma treatment options, have your questions answered, and connect with a community of people affected by multiple myeloma.

EVENT REGISTRATION

January 01, 000112:00AM

*All information is required.

Please complete all required form fields.

*First name

*Last name

*Phone number

*Email address

*Confirm email address

*Address line 1

Address line 2

*City

*State

*ZIP code

*GenderFemaleMale

How many guests will be attending the program with you?

YES, I would like Takeda Oncology to communicate with me regarding Takeda products and services.

Check this box to confirm that you agree to the Takeda Terms of Use and Privacy Policy and that Takeda has your permission to communicate with you regarding products and services.

Please read the following concerning Takeda's use of your personally identifiable information:

Takeda and its partner agencies respect your privacy and are committed to the protection of your personal information. We recognize your need for appropriate protection and management of the personally identifiable information you share with us. If you contact us and choose to provide personally identifiable information, we will use it only for the purpose for which you submitted it to us. We may collect and analyze this information for resale purposes, or share your information with any other unaffiliated company or organization. Any and all uses of personally identifiable information comply with all applicable United States laws. By submitting personally identifiable information, you waive any rights you may have under any law of any other country or region.

If you wish to access and amend the personal information you are sharing about yourself on this event registration page, please contact MMunsubscribe@Snow-companies.com.

Takeda may, at any time, revise this Privacy Statement. Data will be handled in accordance with policy in effect at the time the data are collected. If you have any questions about this privacy statement, please contact Privacy@Snow-companies.com.

By registering for this program, you acknowledge that you understand the above statement and consent to Takeda's use of the personally identifiable information you share with Takeda.

NINLARO is a prescription medicine used to treat multiple myeloma in combination with the medicines REVLIMID® (lenalidomide) and dexamethasone, in people who have received at least one prior treatment for their multiple myeloma.

It is not known if NINLARO is safe and effective in children.

NINLARO may cause serious side effects, including:

Low platelet counts (thrombocytopenia) are common with NINLARO and can sometimes be serious. You may need platelet transfusions if your counts are too low. Tell your healthcare provider if you have any signs of low platelet counts, including bleeding and easy bruising.

Stomach and intestinal (gastrointestinal) problems. Diarrhea, constipation, nausea, and vomiting are common with NINLARO and can sometimes be severe. Call your healthcare provider if you get any of these symptoms and they do not go away during treatment with NINLARO. Your healthcare provider may prescribe medicine to help treat your symptoms.

Nerve problems are common with NINLARO and may also be severe. Tell your healthcare provider if you get any new or worsening symptoms including: tingling, numbness, pain, a burning feeling in your feet or hands, or weakness in your arms or legs.

Swelling is common with NINLARO and can sometimes be severe. Tell your healthcare provider if you develop swelling in your arms, hands, legs, ankles, or feet, or if you gain weight from swelling.

Skin Reactions. Tell your healthcare provider if you get a new or worsening rash.

Liver problems. Tell your healthcare provider if you get these signs of a liver problem: yellowing of your skin or the whites of your eyes; pain in your right upper-stomach area.

Other common side effects have occurred. Tell your healthcare provider if you get new or worsening back pain, lowered white blood cells (neutropenia) that may increase the risk of infection, or vision conditions such as blurred vision, dry eye, or pink eye (conjunctivitis).

These are not all the possible side effects of NINLARO. Talk to your healthcare provider for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

You or your partner are pregnant or plan to become pregnant. NINLARO can harm your unborn baby. Avoid becoming pregnant during treatment with NINLARO. You and your partner should use effective birth control during treatment and for 90 days after the final dose of NINLARO. If using hormonal contraceptives (for example, the pill), an additional barrier method of contraception (for example, diaphragm or condom) must be used.

You are breastfeeding or plan to breastfeed. Do not breastfeed during treatment with NINLARO and for 90 days after your final dose of NINLARO.

Tell your healthcare provider about all the medications (prescription and over-the-counter) and nutritional supplements you are taking or before starting any new medicines.